Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2013
03/14/2013CA2844652A1 Pde10 modulators
03/13/2013EP2566853A1 Tetrazolones as inhibitors of fatty acid synthase
03/13/2013EP2566851A1 Combretastatin analogs for use in the treatment of cancer
03/13/2013CN1953967B Purification of progesterone receptor modulators
03/13/2013CN102971313A Novel glucokinase activators and methods of using same
03/13/2013CN102971305A Heterocyclic antiviral compounds
03/13/2013CN102971302A 6-acyl-1,2,4-triazine-3,5-dione derivative and herbicides
03/13/2013CN102971291A Novel amide derivative and use thereof as medicine
03/13/2013CN102971290A Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof
03/13/2013CN102391254B Preparation method of Candesartan
03/12/2013US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
03/12/2013US8394815 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
03/12/2013US8394807 Quinazoline inhibitors of BACE 1 and methods of using
03/12/2013US8394806 2-phenyl pyrazines as tubulin inhibitors
03/12/2013US8394803 Gyrase inhibitors and uses thereof
03/12/2013US8394510 Aromatic amine derivative and organic electroluminescence device using the same
03/12/2013US8394351 Synthesis of triazole-based and imidazole-based zinc catalysts
03/12/2013CA2731773C Amidophenoxyindazoles useful as inhibitors of c-met
03/12/2013CA2695088C Novel piperazine amide derivatives
03/12/2013CA2637933C Indole sulfonamide modulators of progesterone receptors
03/12/2013CA2517077C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/12/2013CA2388505C 5-membered heterocycle derivatives, their preparation and application as medicine
03/07/2013WO2013033246A2 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
03/07/2013WO2013032297A1 Benzocarbazole compounds and electroluminescent devices involving them
03/07/2013WO2013032284A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/07/2013WO2013032278A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/07/2013WO2013031922A1 Pyrazole compound and use thereof for medical purposes
03/07/2013WO2013030750A1 Antiviral compounds
03/07/2013WO2013030665A1 Pyrimidines as sodium channel blockers
03/07/2013WO2013001505A3 Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/07/2013US20130060041 Synthesis of substituted pyrazoline carboxamidine derivatives
03/07/2013US20130060030 Process for the preparation of highly pure crystalline imatinib base
03/07/2013US20130059873 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
03/07/2013US20130059871 Pyrimidine derivatives for the treatment of amyloid-related diseases
03/07/2013US20130059860 Naphthalene carboxamide m1 receptor positive allosteric modulators
03/07/2013US20130059856 Agonists of gpr131 and uses thereof
03/07/2013US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions
03/07/2013US20130059847 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors
03/07/2013US20130059845 Bicyclic agonists of gpr131 and uses thereof
03/07/2013US20130059833 Pde10 modulators
03/07/2013US20130059343 Nucleotide derivatives
03/07/2013US20130058892 Pyrimidinyl indole compounds
03/07/2013US20130056720 Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode
03/07/2013US20130056175 Use of compounds with nitrogen-containing functional groups for thermal energy storage
03/07/2013US20130056075 Compounds for use in electrolyte for solar cell, method for preparing the same, and electrolyte and solar cell having the same
03/07/2013CA2847247A1 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof
03/07/2013CA2846463A1 Pyrimidines as sodium channel blockers
03/07/2013CA2845127A1 Pyrazole compound and pharmaceutical use thereof
03/07/2013CA2844521A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
03/06/2013EP2565185A1 [5,6]heterocyclic compound
03/06/2013EP2563775A1 Pyrazolyl quinazoline kinase inhibitors
03/06/2013EP2563774A1 Pyrimidinyl indole compounds
03/06/2013EP2563368A1 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders
03/06/2013EP2563123A1 Novel beta 3 adrenergic receptor agonists
03/06/2013CN102958928A Dimeric SMAC Mimetics
03/06/2013CN102958927A Indazole inhibitors of kinase
03/06/2013CN102958925A Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer
03/06/2013CN102958917A Compositions and methods for modulating the wnt signaling pathway
03/06/2013CN102958915A Compound having carbazole ring structure, and organic electroluminescent device
03/06/2013CN102952120A Compound for electroluminescent device and organic electroluminescent devices using the same
03/06/2013CN102952118A Poly(ADP-ribose)polymerase inhibitor, preparation method and application thereof
03/06/2013CN102015627B Amide compounds, preparation methods and uses thereof
03/06/2013CN101119988B Chemical compouns
03/05/2013USRE44048 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder
03/05/2013US8389723 Deuterated benzene sulfonamide thiazole compounds
03/05/2013US8389718 Insecticidal triazines and pyrimidines
03/05/2013US8389717 Modulators for amyloid beta
03/05/2013US8389562 Polymorphic forms of a 3-pyrrole substituted 2-indolinone
03/05/2013US8389521 Inhibitors of protein kinases
03/05/2013US8389442 N-phenyl-′(4-pyridyl)-azinyl!amine derivatives as plant protection agents
02/2013
02/28/2013WO2013027845A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals
02/28/2013WO2013027168A1 Novel heterocyclic compounds as bromodomain inhibitors
02/28/2013WO2013026914A1 Serine/threonine pak1 inhibitors
02/28/2013WO2013026163A1 Hepatitis c inhibitor compounds
02/28/2013US20130053563 Prodrug of triazolone compound
02/28/2013US20130053558 Organic compounds for electroluminescent devices
02/28/2013US20130053409 2-(2,4,5-substituted-anilino) pyrimidine compounds
02/28/2013US20130053403 Novel beta 3 adrenergic receptor agonists
02/28/2013US20130053386 Diaryl ether derivatives as notch sparing gamma secretase inhibitors
02/28/2013US20130053384 Certain Chemical Entities, Compositions, and Methods
02/28/2013US20130053381 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives
02/28/2013US20130053372 5-ht receptor modulators
02/28/2013US20130053362 Heterocyclic compounds and uses thereof
02/28/2013US20130053308 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2a RECEPTOR ANTAGONISTS
02/28/2013US20130052205 Flt3 receptor antagonists for the treatment or the prevention of pain disorders
02/28/2013US20130052130 Branched Discreet PEG Constructs
02/28/2013US20130048975 Phenanthrocarbazole compound, and organic electroluminescent device using same
02/28/2013US20130048971 Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device
02/28/2013US20130048956 Compound for electroluminescent device and organic electroluminescent devices using the same
02/28/2013US20130048955 Heterocyclic compound and organic light-emitting device containing the same
02/28/2013DE102011111991A1 Neue Cyclosporin-Derivate New cyclosporin derivatives
02/28/2013CA2846122A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals
02/28/2013CA2844729A1 Serine/threonine pak1 inhibitors
02/27/2013EP2562174A1 Herbicidal 6-Oxo-1,6-dihydropyrimidin-5-carboxamides and 2-Oxo-1,2-dihydropyridin-3-carboxamides
02/27/2013EP2562168A1 Therapeutic piperazines as PDE4 inhibitors
02/27/2013EP2562167A1 5-fluoro pyrimidine derivatives as fungicides
02/27/2013EP2562165A1 5-fluoro pyrimidine derivatives as fungicides
02/27/2013EP2562164A1 5-fluoro pyrimidine derivatives as fungicides
02/27/2013EP2562163A1 5-fluoro pyrimidine derivatives as fungicides
02/27/2013EP2562161A1 5-fluoro pyrimidine derivatives as fungicides
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 626